Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States

BACKGROUND: Prior to 2018, intravenous bisphosphonates (IV BPs) were the only therapies recommended to prevent skeletal‐related events for patients diagnosed with multiple myeloma (MM). We examined patterns of IV BP initiation and interruption among patients with newly diagnosed MM (NDMM) in the Uni...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Med
Hauptverfasser: McGrath, Leah J., Hernandez, Rohini K., Overman, Robert, Reams, Diane, Liede, Alexander, Brookhart, M. Alan, O’Donnell, Elizabeth
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2018
Schlagworte:
Cancer Prevention
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6346250/
https://ncbi.nlm.nih.gov/pubmed/30537194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1869
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge